Oxidized cholesterol as the driving force behind the development of Alzheimer’s disease
Alzheimer’s disease (AD), the most common neurodegenerative disorder associated with dementia, is typified by the pathological accumulation of amyloid β peptides and neurofibrillary tangles within the brain. Considerable evidence indicates that many events contribute to AD progression, including oxi...
Main Authors: | Paola eGamba, Gabriella eTesta, Simona eGargiulo, Erica eStaurenghi, Giuseppe ePoli, Gabriella eLeonarduzzi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2015-06-01
|
Series: | Frontiers in Aging Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fnagi.2015.00119/full |
Similar Items
-
Cholesterol Dysmetabolism in Alzheimer’s Disease: A Starring Role for Astrocytes?
by: Erica Staurenghi, et al.
Published: (2021-11-01) -
A Crosstalk Between Brain Cholesterol Oxidation and Glucose Metabolism in Alzheimer’s Disease
by: Paola Gamba, et al.
Published: (2019-05-01) -
Changes in brain oxysterols at different stages of Alzheimer's disease: Their involvement in neuroinflammation
by: Gabriella Testa, et al.
Published: (2016-12-01) -
The Controversial Role of 24-S-Hydroxycholesterol in Alzheimer’s Disease
by: Paola Gamba, et al.
Published: (2021-05-01) -
Oxysterols present in Alzheimer's disease brain induce synaptotoxicity by activating astrocytes: A major role for lipocalin-2
by: Erica Staurenghi, et al.
Published: (2021-02-01)